Menopause before 45 — or premature ovarian insufficiency before 40 — carries unique health implications that require specialist management and early hormonal support.
Early menopause and POI are related but clinically distinct. Understanding the difference matters for diagnosis, treatment and prognosis.
Natural menopause
Age 45–55
Average age 51 in South Africa
Early menopause
Before age 45
Menopause confirmed (12 months no periods)
POI (Premature Ovarian Insufficiency)
Before age 40
Formerly called 'premature ovarian failure'
7 min read
8 min read
8 min read
8 min read
7 min read
8 min read
9 min read
6 min read
6 min read
9 min read
6 min read
8 min read
Early menopause and premature ovarian insufficiency are diagnoses that profoundly affect women at a stage of life when they are least expecting hormonal changes. The impact extends far beyond symptoms — it touches fertility, identity, long-term health and emotional wellbeing in ways that require specialised, compassionate care. In South Africa, awareness of POI remains low, and many women spend years receiving incorrect diagnoses before the true hormonal picture is identified.
The most important clinical message is that HRT in early menopause is fundamentally different from HRT in natural menopause at 51. In this context, HRT is simply replacing hormones that the body should still be producing. The risks of not treating — osteoporosis, cardiovascular disease, cognitive decline, sexual dysfunction — are far more clinically significant than any treatment risk at this age. All major menopause and endocrinology societies recommend HRT until at least age 51 for women with early menopause or POI.
HealthLab is committed to ensuring that South African women with early menopause or POI have access to accurate, up-to-date information and can find the right specialist care. Our professional directory includes gynaecologists, endocrinologists and menopause specialists experienced in managing these conditions across South Africa’s nine provinces.